James Kang
Impact in
-
- Curcumin's Biomedical Applications
-
- Immune Response and Inflammation
- interferon and immune responses
Papers in
-
- Ubiquitin and proteasome pathways 1
- Cell death mechanisms and regulation 1
- RNA Interference and Gene Delivery 1
-
- interferon and immune responses 1
- Co-authors
- Eri S. Srivatsan (3 shared papers)Marilene B. Wang (3 shared papers)Khatoun Al Moussawi (1 shared paper)Russell E. Vance (1 shared paper)Isabella Rauch (1 shared paper)Chulho Kang (1 shared paper)Barbara I. Kazmierczak (1 shared paper)Jeannette L. Tenthorey (1 shared paper)
- Journals
- Clinical Breast Cancer (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)European Journal of Biochemistry (1 paper)Bioorganic & Medicinal Chemistry (1 paper)Journal of the American Society for Mass Spectrometry (1 paper)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
James Kang
12 papers receiving 286 citations
Peers
Comparison fields: 5 of 59
- Molecular Medicine 24
- Immunology 71
- Molecular Biology 190
- Otorhinolaryngology 9
- Cancer Research 25
Countries citing papers authored by James Kang
This map shows the geographic impact of James Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Kang more than expected).
Fields of papers citing papers by James Kang
This network shows the impact of papers produced by James Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Kang. The network helps show where James Kang may publish in the future.
Co-authors
The 25 scholars most cited alongside James Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 80 | |
| 2 | 2015 | 64 | |
| 3 | 2009 | 31 | |
| 4 | 2015 | 24 | |
| 5 | 2022 | 22 | |
| 6 | 2004 | 19 | |
| 7 | 2016 | 18 | |
| 8 | 2019 | 14 | |
| 9 | 2004 | 11 | |
| 10 | 2010 | 9 | |
| 11 | 2020 | 1 | |
| 12 | 2017 | 1 |
About James Kang
James Kang is a scholar working on Molecular Biology, Immunology, Cancer Research, Cellular and Molecular Neuroscience and Organic Chemistry, having authored 12 papers that have together received 294 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (2 papers), Neuropeptides and Animal Physiology (2 papers), Ubiquitin and proteasome pathways (1 paper), Vibrio bacteria research studies (1 paper), Cell death mechanisms and regulation (1 paper), Pharmacological Effects and Assays (1 paper), RNA Interference and Gene Delivery (1 paper) and interferon and immune responses (1 paper). The work is most often cited by research in Molecular Medicine (24 citations), Immunology (71 citations), Molecular Biology (190 citations), Otorhinolaryngology (9 citations) and Cancer Research (25 citations). James Kang has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Eri S. Srivatsan, Marilene B. Wang, Khatoun Al Moussawi, Russell E. Vance, Isabella Rauch, Chulho Kang, Barbara I. Kazmierczak, Jeannette L. Tenthorey, Fazlul H. Sarkar and Meera Srivastava. Their work appears in journals such as Clinical Breast Cancer, Bioorganic & Medicinal Chemistry Letters, European Journal of Biochemistry, Bioorganic & Medicinal Chemistry and Journal of the American Society for Mass Spectrometry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.